Components
| 0.4 ml | 1 ml | Componentr> |
| 2 × 0.2 ml | 5 × 0.2 ml | NovaBlue Competent Cellsr> |
| 2 × 2 ml | 4 × 2 ml | SOC Mediumr> |
| 10 µl | 10 µl | Test Plasmid |
General description
This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges us to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
NovaBlue is a K-12 strain ideally suited as an initial cloning host due to its high transformation efficiency, blue/white screening capability (with appropriate plasmids) and recA endA mutations.
NovaBlue is a K-12 strain ideally suited as an initial cloning host due to its high transformation efficiency, blue/white screening capability (with appropriate plasmids) and recA endA mutations, which result in high yields of excellent quality plasmid DNA. The DE3 lysogen of NovaBlue is potentially useful as a stringent host due to the presence of the lacIq repressor encoded by the F episome. Blue/white screening is not possible with NovaBlue(DE3) due to the presence of the lacZ α-peptide coding sequences in the lysogenic phage.
Legal Information
NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany
Packaging
0.4, 1 ml in Glass bottle
Warning
Toxicity: Multiple Toxicity Values, refer to MSDS (O)
This product has met the following criteria: